The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

Business debate on research and innovation (R&I) funding in the EU’s new mandate, global health leaders underlined the ...

Three species of mosquito are of particular concern in Europe, according to the European Centre for Disease Prevention and ...

It's a big, germy world out there. If you want to travel with peace of mind, learn the basics of vaccines, illnesses, and ...

If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...

Here’s a look at Zika virus, an illness spread through mosquito bites that can cause birth defects and other neurological defects. Facts Sources: Centers for Disease Control and Prevention (CDC), ...

The illness typically lasts two to seven days, but severe cases can be deadly. An affected person will have flu-like symptoms ...

SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the 'Company') declared today that it is ready to fight the bird f ...

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...

Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...